RYM FINANCIAL STATEMENTS

Ryman Healthcare Limited — balance sheet, income statement and cash flow trends

RYMRyman Healthcare Limited

🇦🇺 Australia · AU · Healthcare · Medical Care Facilities

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue1.2 B NZD—

Gross Profit-69.2 M NZD—

Operating Income-69.2 M NZD—

EBITDA-255.4 M NZD—

Net Income-703.4 M NZD—

Peer Comparison· Medical Care Facilities

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
RYM	215.1%	-5.9%	-21.8%	-60.1%
USPH	9.1%	20.4%	14.2%	0.2%
AMN	19.9%	27.6%	5.9%	-0.9%
PNTG	36.8%	14.8%	5.9%	3.0%
CYH	69.8%	53.7%	23.1%	-0.4%
INNV	13.7%	20.7%	0.5%	-2.3%
Industry median	10.2%	27.7%	13.8%	3.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity4.1 B NZD33%
Current Liabilities320.3 M NZD3%
Long-term Liabilities7.9 B NZD64%

Key Figures

YoY change

Total Assets12.4 B NZD—

Total Liabilities8.2 B NZD—

Total Equity4.1 B NZD—

Cash & ST Investments9.8 M NZD—

Total Debt1.6 B NZD—

Net Debt1.6 B NZD—

Peer Comparison· Medical Care Facilities

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
RYM	0.55	39.0%	-6.24	33.2%
USPH	1.19	77.4%	3.23	37.8%
AMN	1.09	109.0%	1.07	27.4%
PNTG	1.19	130.9%	7.46	36.2%
CYH	1.47	-739.8%	2.02	-11.0%
INNV	1.03	41.0%	-10.28	41.8%
Industry median	1.26	59.9%	1.87	35.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow426.9 M NZD—

Capital Expenditures60.5 M NZD—

Free Cash Flow366.4 M NZD—

Dividends Paid——

Peer Comparison· Medical Care Facilities

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
RYM	36.5%	31.3%	5.2%	-60.7%
USPH	11.5%	9.2%	2.3%	7,096.3%
AMN	21.6%	20.7%	1.0%	-2,278.5%
PNTG	6.5%	4.6%	1.8%	218.1%
CYH	0.6%	-0.9%	1.5%	-143.2%
INNV	5.3%	4.1%	1.2%	-226.4%
Industry median	10.4%	5.8%	3.6%	165.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RYM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.